Disc Medicine (IRON) Receives a Buy from LifeSci Capital
Disc Medicine (IRON) Receives a Buy from LifeSci Capital is drawing significant interest across the industry.
LifeSci Capital analyst Rami Katkhuda maintained a Buy rating on Disc Medicine today and set a price target of $100.00.President's Day Sale - 70...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- High school girls wrestling: Duchesne continues reign with third 2A/1A state championship
- (VIDEO) Trump Announces Termination of Obama-Era "Endangerment Finding" on Greenhouse Gasses, Repealing Auto Stop-Start Feature and Green Emissions Standards in Cars - Obama Responds!
- Ted Lasso actor may be close to joining USL's Locomotive FC
- Bombay High Court Reserves Order on Controversial Goa Mineral Policy 2023
Source: Original →